Skip to the main content.

Cell and Gene Therapy Series. Part 1 - Converting a Rolls-Royce into a Ford?

Dr. Dave Seaward : 20 January 2022

Cell and Gene Therapy Series. Part 1 - Converting a Rolls-Royce into a Ford?

PDF File: Cell and Gene Therapy: Converting a Rolls-Royce into a Ford?

With promising applications in the personalised medicines field, Cell and Gene Therapies are becoming more and more relevant. This, alongside 3Ps experience in the manufacturing of said therapies, has inspired 3P Founder and Projects Director Dave Seaward, to write a new blog series all about ATMPs!

Click the pdf link above and take a read of the first blog in the series.

This first blog focuses around the manufacture of cell and gene therapies with an interesting analogy to the automotive industry. It also looks at how 3P innovation can help with the manufacture of these life-changing ATMPs.
Still Pipette-Filling Cryovials? There’s a Better Way

Still Pipette-Filling Cryovials? There’s a Better Way

Dr. Dave Seaward: 23 June 2025

In cell and gene therapy, where fill precision and cell viability can determine the success of an entire treatment, it's surprising how many...

Vial Closing cell gene
Read More
International Women in Engineering Day

International Women in Engineering Day

Louise Fellows: 23 June 2025

Each year on 23 June, International Women in Engineering Day (INWED), led by the Women’s Engineering Society, shines a spotlight on the remarkable...

Read More
Ensuring cGMP compliance in cell and gene therapy manufacturing

Ensuring cGMP compliance in cell and gene therapy manufacturing

Dr. Dave Seaward: 16 June 2025

In the evolving field of cell and gene therapy (CGT), adherence to current Good Manufacturing Practice (cGMP) is crucial. This white paper provides...

Read More